Susquehanna Fundamental Investments, LLC Praxis Precision Medicines, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.88 - $36.45 $20,226 - $392,165
-10,759 Reduced 14.74%
62,252 $148,000
Q3 2022

Nov 14, 2022
BUY
$2.5 - $37.95 $141,395 - $2.15 Million
56,558 Added 343.75%
73,011 $166,000
Q1 2022

May 16, 2022
SELL
$10.21 - $20.29 $19,470 - $38,693
-1,907 Reduced 10.39%
16,453 $168,000
Q4 2021

Feb 14, 2022
BUY
$16.76 - $22.99 $307,713 - $422,096
18,360 New
18,360 $362,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $2.62B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email